Remedium Lifecare Hits 52-Week Low, Given 'Sell' Call by MarketsMOJO
Remedium Lifecare, a microcap company in the trading industry, has hit a 52-week low on August 20, 2024, with a current stock price of Rs.8.37. The stock has been given a 'Sell' call by MarketsMojo and has underperformed the sector by -4.82%. It is also trading below its moving averages, indicating a bearish trend. Investors should carefully consider the stock's performance before making any investment decisions.
Remedium Lifecare, a microcap company in the trading industry, has recently hit a 52-week low on August 20, 2024. According to MarketsMOJO, the stock has been given a 'Sell' call. The current price of the stock is Rs.8.37, which is the lowest it has been in the past year.
In today's trading, Remedium Lifecare has underperformed the sector by -4.82%. This is in line with the stock's performance over the past 12 days, where it has been on a downward trend and has seen a -40.43% decrease in returns.
The stock is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. This could be a cause for concern for investors.
In comparison to the Sensex, Remedium Lifecare's performance over the past year has been significantly lower, with a -79.41% decrease in returns. This is in contrast to the Sensex's positive performance of 24.13%.
It is important for investors to carefully consider the current state of Remedium Lifecare before making any investment decisions. With the stock hitting a 52-week low and underperforming the sector and Sensex, it may be wise to approach with caution.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
